Estatísticas para RT 1537 2019 - Ocrelizumabe, esclerose múltipla - NATJUS TJMG
Total de visitas
| views | |
|---|---|
| RT 1537 2019 - Ocrelizumabe, esclerose múltipla - NATJUS TJMG | 2 |
Total visitas por mês
| views | |
|---|---|
| July 2025 | 0 |
| August 2025 | 0 |
| September 2025 | 0 |
| October 2025 | 0 |
| November 2025 | 0 |
| December 2025 | 1 |
| January 2026 | 0 |
Visitas Arquivos
| views | |
|---|---|
| RT 1537.pdf | 14 |